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Abstract
Carbon-13 nuclear magnetic resonance spectroscopy in combination with the infusion of 13C-labeled precursors is a unique
approach to study in vivo brain energy metabolism. Incorporating the maximum information available from in vivo localized
13C spectra is of importance to get broader knowledge on cerebral metabolic pathways. Metabolic rates can be quantitatively
determined from the rate of 13C incorporation into amino acid neurotransmitters such as glutamate and glutamine using
suitable mathematical models. The time course of multiplets arising from 13C-13C coupling between adjacent carbon atoms
was expected to provide additional information for metabolic modeling leading to potential improvements in the estimation
of metabolic parameters.
The aim of the present study was to extend two-compartment neuronal/glial modeling to include dynamics of 13C isotopomers
available from fine structure multiplets in 13C spectra of glutamate and glutamine measured in vivo in rats brain at 14.1 T, termed
bonded cumomer approach. Incorporating the labeling time courses of 13C multiplets of glutamate and glutamine resulted in
elevated precision of the estimated fluxes in rat brain as well as reduced correlations between them.
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A powerful approach to study brain metabolism has been
the combination of 13C-enriched substrates and in vivo
magnetic resonance spectroscopy (MRS; Gruetter, 2002;
Mason and Rothman, 2004; Henry et al., 2006; Lanz
et al., 2013b; Rodrigues et al., 2013). Nuclear magnetic
resonance (NMR) measurements enable detection of 13C
label incorporation from infused 13C-enriched substrate
(e.g., glucose) into diﬀerent carbon positions of amino
acids in brain such as glutamate (Glu), glutamine (Gln),
and aspartate (Asp) (de Graaf et al., 2003; Gruetter et al.,
2003).
Metabolic modeling of Carbon labeling time courses
of amino acids in brain allows quantitative measurements
of metabolic ﬂuxes in vivo (Gruetter et al., 2001;
Rothman et al., 2003; Oz et al., 2004; Lanz et al.,
2012). In the past decade, questions have been raised
concerning the reliability of some estimated ﬂuxes in
brain (Shestov et al., 2007; Uﬀmann and Gruetter,
2007; Shen et al., 2009) and many eﬀorts have been
undertaken to improve their accuracy through
adaptation of the metabolic models used to analyze the
13C turnover curves. Monte–Carlo simulations showed
that an increased number of measured time courses of
13C positions of Glu and Gln as input for the metabolic
modeling analysis resulted in an improved precision and
reliability of brain metabolic ﬂuxes (Shestov et al., 2007).
However, the number of measured 13C labeling time
courses of metabolites relies on the NMR detection
method, the chosen magnetic ﬁeld strength and pulse
sequence in diﬀerent studies, and varied from two to
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seven 13C uptake curves (Mason et al., 1995; Gruetter
et al., 2001; Choi et al., 2002; de Graaf et al., 2004; Xin
et al., 2010, 2015).
Due to the diﬃculty of measuring 13C multiplets of Glu
andGln in vivowithhigh temporal resolution, derivationof
metabolic ﬂuxes has been performed almost exclusively
using dynamic positional enrichment (e.g., de Graaf
et al., 2003; Gruetter et al., 2003; Henry et al., 2006;
Duarte et al., 2011) which is the time course of total 13C
enrichment of each carbon position of each metabolite.
The measurement of labeling time courses of 13C iso-
topomers noninvasively in the rat brain has been already
reported by Henry et al. (2003a). A ﬁrst analysis of in vivo
measured 13C dynamic labeling of isotopomers in a heart
metabolic study led to improved precision of the esti-
mated tricarboxylic acid (TCA) cycle ﬂux (Jeﬀrey et al.
1999). In a study of brain metabolism by the same group,
the 13C time courses of the singlet and doublet of cerebral
Glu labeled at position C4 was included in the metabolic
analysis and resulted in a poorer determination of glu-
tamate/alpha-ketoglutarate and oxaloacetate/aspartate
exchange rate, called Vx (Jeﬀrey et al., 2013), probably
reﬂecting the incomplete description of the Glu C4 singlet
turnover by the considered metabolic model.
Recently, a new 13C metabolic modeling approach
using the concept of bonded cumomers was proposed,
taking full advantage of the available time courses of
13C multiplets of Glu and Gln in the metabolic model
(Shestov et al., 2012). In simulations, the bonded cumo-
mer approach led to better precision than the positional
approach in the determination of brain metabolic ﬂuxes
using artiﬁcial 13C time courses of Glu and Gln multiplets
generated with the two-compartmental description of
brain energy metabolism (Gruetter et al., 2001) for diﬀer-
ent infused 13C-labeled substrates.
Including the individual time courses of 13C multiplets
in the metabolic modeling process is expected to provide
increased number and precision of the metabolic ﬂuxes of
interest. Therefore, the aim of this study was to incorp-
orate the 13C dynamic labeling of observable multiplets of
Glu and Gln measured with in vivo 13C MRS in the rat
brain at 14.1 T to estimate brain metabolic ﬂuxes in the
case of a neuronal–glial compartmentalized metabolic
network, under infusion of [1,6-13C2] glucose.
Methods
Animal Preparation
All animal procedures were performed according to
federal guidelines and were approved by the local ethics
committee from the canton Vaud, Switzerland. The pre-
sented 13C-glucose infusion studies were performed follow-
ing a previously described protocol (Duarte et al., 2011).
Brieﬂy, four male Sprague–Dawley rats (276 11g,
delivered from Charles River Laboratories, France) were
fasted for 6 hr prior to the NMR experiment. Animals
were intubated and ventilated with 2% isoﬂurane during
surgery. Both femoral veins were catheterized for the
administration of glucose and a-chloralose for anesthesia.
Two arteries were cannulated for continuous monitoring
of physiology (blood pressure and heart rate) and periodic
blood sampling for blood gas, plasma lactate, and glucose
concentration measurements as well as for further high
resolution NMR analyses of 13C enrichment of substrates.
Body temperature was maintained between 37.0 and
37.5C with a temperature-regulated circulating water
bath. Following surgery, anesthesia was switched to intra-
venous a-chloralose administration (bolus of 80mg/kg and
continuous infusion rate of 28mg/kg/hr). Animals were
placed in a home-built holder and the head position was
ﬁxed using ear rods and a bite bar.
After adjustment of MRS parameters, an exponen-
tially decaying 5-min bolus of 99%-enriched [1,6-13C2]
glucose (1.1M in saline solution) was administered. The
volume of this bolus was adapted to the basal glycemia in
order to reach 70% plasma glucose fractional enrichment
(FE) at the end of the 5min. The bolus was followed by a
continuous infusion of 70%-enriched glucose at a rate
equivalent to the whole body glucose disposal rate of
33.2mg/kg/min (Jucker et al., 2002) and adjusted based
on periodically measured arterial plasma glucose concen-
trations in order to maintain a constant glycemia of
350mg/dl throughout the experiment. This protocol
results in a stable 70% plasma glucose FE reached
within 5min (Henry et al., 2002). At the end of experi-
ment, rats were sacriﬁced and brain extracts prepared as
previously described (Duarte et al., 2007) for further pro-
cessing and analysis.
In Vivo and In Vitro NMR Spectroscopy
All in vivo spectra were acquired on a 14.1 T magnetic
resonance imaging system interfaced to a 26-cm hori-
zontal bore magnet (Magnex Scientiﬁc, Oxford, UK;
Varian, Palo Alto, CA), equipped with 12-cm inner
diameter actively shielded gradients reaching 400mT/m
in 120 ms. The coil assembly consisted of a home-built
1H quadrature surface coil and an inner 13C linearly
polarized surface coil.
After initial setting, fast spin echo images (TR¼ 5 s
and TE¼ 52ms; eight echoes) were acquired to select a
volume of interests of 320 ml in the brain. Magnetic ﬁeld
homogeneity was adjusted using FAST(EST)MAP
(Gruetter and Tka´c, 2000). Localized 1H NMR spectra
were acquired using the spin-echo full-intensity acquired
localized spectroscopy (SPECIAL) sequence (echo time
of 2.8ms and repetition time of 4 s). During the labeling
experiment, Carbon-13 NMR (13C NMR) spectra were
acquired in vivo using the semi-adiabatic distortionless
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enhancement by polarization transfer (DEPT) technique
combined with 3D-ISIS 1H localization (Henry et al.,
2003b). Water-soluble metabolites from brain extracts
and plasma samples were quantiﬁed by 1H and 13C
NMR spectroscopy with a 14.1 T DRX-600 spectrometer
equipped with a 5-mm cryoprobe (BrukerBioSpin SA,
Fa¨llanden, Switzerland).
Spectral Analysis
The signal-to-noise ratio (SNR) of acquired 13C spectra is
an important factor for the accuracy and precision in
quantiﬁcation of individual 13C multiplets of Glu and
Gln labeled at positions C4, C3, and C2. To achieve
higher SNR, a possibility is to increase temporal aver-
aging of 13C spectra acquired with 5.3min time reso-
lution. After correction for phase and frequency drifts,
consecutive MRS acquisition blocks were summed two
by two resulting in dynamic spectral data with 10.6min
resolution. For every time point, the 10.6-min spectra
from four animals were combined to a single data set
after correction for frequency drifts. In the averaging pro-
cess, the possible time shifts between diﬀerent animals due
to intermediate periods of shimming were taken into
account. Summed 13C NMR in vivo spectra were processed
using LCModel (Stephen Provencher Inc., Oakville,
Ontario, Canada). The basis sets for LCModel were gen-
erated using Matlab (TheMathWorks, Natick, MA) by
simulating each 13C isotopomer with the appropriate che-
mical-shift and J-coupling pattern as described by Henry
et al. (2003b). The dynamically measured 13C spectra were
scaled based on the Glu pool size measured with 1H MRS
and the FE of GluC3, which was determined with the
following formula: FE (C3)¼C4 D34/(C4 SþC4 D34)
where C4 D34 indicates area of the C4 doublet resulting
from double labeling of Glu at position C4 and C3, and C4
S the singlet area of Glu at position C4. Multiplets of
GluC4 resonances were averaged over the last 30min,
assuming steady-state enrichment for GluC4 at this later
stage of infusion.
Correction factors, found by in vitro 13C NMR spectra
from brain extracts and standard solutions containing the
metabolites of interest (Duarte & Gruetter, 2013), were
applied to account for the relative diﬀerent eﬃciencies in
signal enhancement by polarization transfer in DEPT for
the considered carbon positions of Glu and Gln.
Metabolic Modeling
The 13C turnover curves of Glu and Gln were analyzed
using a metabolic model built based on the bonded
cumomers concept (Shestov et al., 2012) in the case of a
two-compartment neuronal–glial metabolic network
description (adapted from Gruetter et al., 2001) shown
in Figure 1. This model was adapted to include a nonzero
concentration of aspartate in the glial compartment and a
dilution factor at the level of glial acetyl-CoA as in our
previous study (Duarte et al., 2011). This model intro-
duces and assesses a new metabolic modeling approach
that allows the analysis of individual 13C multiplets time
courses of in vivo NMR spectra of the rat brain.
The principles of bonded cumomers modeling were
explained comprehensively by Shestov et al. (2012).
In summary, a cumomer fraction, noted pM{i}, is the
sum of isotopomer fractions for all isotopomers of
the molecule M labeled at least at the set of positions
if g ¼ i1, i2, . . . , in independently from the label at other
positions. The size n of the set {i} will be referred to as
Figure 1. The neuronal–glial compartmentalized metabolic network used for the different metabolic modeling approaches.
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the order of the p function. Bonded cumomers model
consider those cumomers whose indexes refer to adjacent
carbons because all possible metabolites isotopomers are
not detectable in vivo by NMR. As four diﬀerent splitting
patterns are possible for any carbon with two direct
carbon neighbors, they can be expressed in terms of the
bonded ’ bonded cumomers of order n 3.
The following equation shows the transformation for
all observable Glu multiplets of the position C4 in a 13C
spectrum, where the indexes S, D, and Q refer to singlet,
doublet, and doublet of doublet in the GluC4 signal, to
the related cumomer fractions:
GluC4 Q
GluC4 D43
GluC4 D45
GluC4 S
0
BB@
1
CCA ¼
0 0 0 1
0 1 0 1
0 0 0 1
1 1 1 1
0
BB@
1
CCA
Glu 4f g
Glu 3, 4f g
Glu 4, 5f g
Glu 3, 4, 5f g
0
BB@
1
CCA
Furthermore, if the couplings with the two neighbor-
ing carbons in the carbon chain of a given metabolite are
identical, such as for C3 of Glu, the above equation sim-
pliﬁes to the following transformation, where the index T
represents the triplet signal:
GluC3 T
GluC3 D
GluC3 S
0
@
1
A ¼ 0 0 0 10 1 1 2
1 1 1 1
0
@
1
A
Glu 3f g
Glu 2, 3f g
Glu 3, 4f g
Glu 2, 3, 4f g
0
BB@
1
CCA:
In the equation above, intensities are normalized so
that the total signal is the sum of all multiplet compo-
nents. For example, in the case of GluC4, we have:
GluC4 tot ¼ GluC4 QþGluC4 D43
þGluC4 D45þGluC4 S:
The system of diﬀerential equations that describes
labeling of all observable multiplets of Glu and Gln
and the principal chemical intermediates implied in the
generation of these multiplets was derived. The ﬁnal
system describing the incorporation of 13C from labeled
glucose into the multiplets of Glu and Gln consisted in a
total of 133 diﬀerential equations (see Appendix).
The Cramer–Rao lower bounds (CRLBs) obtained
from the LCModel spectral quantiﬁcation (expressed as
coeﬃcient of variation [%standard deviation, SD]) were
used as a conﬁdence criterion to select the measurable
individual 13C multiplets of each metabolite. The thresh-
old SD to include a multiplet in the metabolic analysis
was set to 15% for every observable 13C multiplet of Glu
or Gln at labeling steady state.
The two-compartment metabolic model was ﬁrst ﬁtted
to the 13C enrichment curves of total concentration of
Glu and Gln C4, C3, and C2 (i.e., the bonded cumomer
model reduced to ﬁrst-order cumomers, i.e., positional
model) over time using the Levenberg–Marquardt algo-
rithm for nonlinear regression, coupled to a Runge–
Kutta method for nonstiﬀ systems to obtain numerical
solutions of the ordinary diﬀerential equations. The dif-
ferent 13C uptake curves used in the regression were
weighted according to square root of the inverse of the
variance (square CRLBs) extracted from the LCModel
quantiﬁcation for every data point of Glu and Gln, to
correct for the overweighting of noisy data in the multiple
curve regression (Cobelli et al., 2000). The reliability of
the estimated ﬂuxes in brain was derived by Monte–Carlo
simulation. Artiﬁcial data sets (500 series) were generated
by adding random Gaussian noise with same variance as
the experimental data to each model turnover curve
obtained from the best ﬁt of the experimental data.
This resulted in 500 data sets with same characteristics
as the experimental data but diﬀerent noise realizations.
All numerical procedures were performed in Matlab
(MathWorks, Natick, MA).
In a second step, the bonded cumomer model was used
for the ﬁtting of the time courses of both the total 13C
enrichment of every carbon position and every NMR-
observable 13C multiplet of Glu and Gln which was
detected experimentally with suﬃcient precision (<15%
CRLB). The precision of the obtained metabolic
ﬂuxes was assessed with an equivalent Monte–Carlo
simulation.
To investigate the particular changes in the correl-
ations and probability distributions of Vdil and Vnt
using both the positional model and bonded cumomer
model, a sensitivity analysis was undertaken for the
ﬂuxes Vdil and Vnt. The mentioned ﬂuxes were con-
strained to a range of chosen values and their eﬀect on
the 13C labeling curves of Glu and Gln in the positional
modeling and bonded cumomer modeling approaches
were compared. For each constrained value of Vdil or
Vnt, the metabolic model was ﬁtted to the measured
total 13C enrichment time courses in positional modeling
and total and multiplets 13C enrichment time courses in
bonded cumomer modeling. In the positional model, the
time courses of 13C multiplets of Glu and Gln were also
simulated in every step of the sensitivity analysis to illus-
trate the separate eﬀect of Vdil and Vnt on the simulated
13C multiplets time courses and therefore the potential of
adding those curves to the metabolic modeling process.
Finally, the eﬀect of removing the time course of total 13C
enrichment of Glu and Gln C4, C3, and C2 in the bonded
cumomer model (referred in following as individual
multiplet model) on the precision of the obtained meta-
bolic ﬂuxes was investigated. Statistical signiﬁcance of
diﬀerences in ﬂux values found with the various modeling
approaches was tested using two-sample unpaired t-test,
corrected for multiple comparisons using Bonferroni cor-
rection when necessary.
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Results
To increase the SNR enabling the measurement of isoto-
pomers at low 13C enrichment, temporal averaging to a
time resolution of 10.6min of the measured 13C MRS
data was used and 13C spectra from diﬀerent animals
were combined prior to spectral quantiﬁcation leading
to spectra of higher quality and SNR (e.g., SNR of 24
after 2 hr [1,6-13C2] Glc infusion, based on the GluC4 S
peak). The high quality of the spectra was judged from
the well-resolved resonances and appearance of multiplet
ﬁne structures of Glu and Gln in spatially localized
1H-decoupled 13C NMR spectra (Figure 2). The total
metabolite concentrations measured by 1H MRS and
averaged over four animals were 8.4 1.2mmol/g for Glu,
4.3 0.3mmol/g for Gln, and 2.5 0.3mmol/g for Asp.
The overlap of the central peak of the triplet and the
singlet resonances of Glu and Gln labeled at position C3
did not enable their individual spectral quantiﬁcation,
especially at low 13C concentrations. A higher estimation
of the triplet was consistently associated with an under-
estimation of the singlet and vice versa. Therefore, the
sum of singlet and triplet resonances in GluC3 and
GlnC3 time courses (GluC3 SþT and GlnC3 SþT)
was considered as input for the cumomer model, taking
advantage of the reliable spectral quantiﬁcation of the
summed multiplets GluC3 SþT and GlnC3 SþT, as
judged from the respective CRLBs being less than 15%
at steady state. The in vivo time courses of total 13C label-
ing of Glu and Gln at carbon position C4, C3, and C2
and their observable 13C multiplets quantiﬁed with SD
lower than 15% were considered for metabolic modeling
analysis during infusion of [1,6-13C2] glucose (Figure 3).
The ﬁtted time courses for the positional model included
the total 13C enrichment of Glu and Gln at positions C4,
C3, and C2. The ﬁtted 13C turnover curves for the bonded
cumomers approach included the following separate
components:
GluC4 total, GluC4 S, GluC4 D43, GluC3 total,
GluC3 SþT, GluC3 D, GluC2 total, GluC2 S, GluC2
D23, GlnC4 total, GlnC4 S, GlnC4 D43, GlnC3 total,
GlnC3 SþT, GlnC3 D, GlnC2 total, GlnC2 S (total 17
curves). The same notation as Henry et al., (2003a) and
Lanz et al. (2013) has been used for the diﬀerent 13C
labeling patterns of Glu and Gln.
To determine the metabolic rates upon infusion of
13C-enriched glucose, either the positional or the bonded
cumomer model was ﬁtted to the aforementioned 13C time
courses. The resulting metabolic rates (Table 1) included
neuronal TCA cycle ðVnpdhÞ, glial TCA cycle
Figure 2. In vivo 13C NMR spectra acquired three hours after starting [1,6-13C2] glucose infusion at 14.1 T from a 320ml volume in the rat
brain (summed spectra from four animals with averaged time of 10.6 min, no apodization applied). (b) The fine structure of Glu and Gln at
position 4, 3, and 2 is depicted in details in the enlarged spectrum.
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VgTCA ¼ Vg þ Vpc
 
, the malate–aspartate shuttle activ-
ity (Vx), apparent neuro transmission ﬂux (Vnt), and glial
anaplerotic pyruvate carboxylation (Vpc). Assuming meta-
bolic steady state for the metabolite pools, the cerebral
metabolic rate of Glc oxidation (CMRglc(ox)), the inﬂow
of labeling from extracerebral lactate (Vin), and the Gln
synthesis rate (Vsyn) were calculated (Table 1) from the
mass balance equations (see A-2). To estimate the pure
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Figure 3. Averaged (four animals) in vivo time courses and model fits of Glu and Gln 13C enrichment using (a) the positional model and (b) the
bonded cumomer model at the carbon positions C4, C3, and C2 during [1,6-13C2] glucose infusion (each time point averaged over 10.6 min).
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eﬀect of individual 13C multiplets of metabolites as input
information for metabolic modeling, brain metabolic
ﬂuxes were also estimated by considering all NMR-obser-
vable multiplets of Glu and Gln without total 13C enrich-
ment time courses (i.e., individual multiplet model) at each
carbon position (Table 1). Overall, the estimated metabolic
ﬂuxes in all three approaches were precisely determined
with SD lower than 20% (determined by Monte Carlo
analysis) which owes to the good quality of input dynamic
13C time courses with adapted time resolution and also the
completeness of the used neuronal-glial metabolic model.
The most signiﬁcant diﬀerences in the value of estimated
ﬂuxes using the diﬀerent mentioned approaches were for
Vnt and Vdil, with diﬀerences of 55% between bonded
cumomer model and positional model and 75% between
individual multiplet model and positional model.
The probability distribution of metabolic ﬂux values,
calculated by Monte Carlo simulation, was ﬁtted with a
gamma distribution for every model (positional model,
individual multiplet model, and bonded cumomer
model) and compared with each other (Figure 4). The
probability density for all estimated ﬂuxes determined
by Monte Carlo simulations approached a Gaussian dis-
tribution for the three modeling approaches, as a conse-
quence of determined ﬂux values clearly diﬀerent from
zero. In general, the distribution of most metabolic
ﬂuxes in every approach was narrow, reﬂecting the pre-
cision of the estimated ﬂuxes and the fact that the models
are numerically identiﬁable. Including 13C multiplets time
courses of Glu and Gln in the bonded cumomer model
resulted in slightly narrower distributions for most
metabolic ﬂuxes. The most signiﬁcant impact was on
Vdil distribution for which the full width at half maximum
(FWHM) of the probability distribution decreased by a
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Figure 4. Probability distribution of the determined metabolic fluxes obtained from Monte Carlo simulations (n¼ 500) and fitted with a
gamma distribution for visualization purposes, in the cases of the positional model, the individual multiplet model and the bonded cumomer
model. The density probability is normalized to the number of simulation, n¼ 500.
Table 1. The Metabolic Fluxes in mmol/g/min (Value SD)
Determined Using Bonded Cumomer Model, Individual Multiplet
Model, and Positional Model.
Bonded
cumomer
Individual
multiplet Positional
Flux (mmol/g/min)
Vg 0. 17 0.02 0.18 0.03 0.13 0.02
Vx 0.48 0.06 0.57 0.12 0.39 0.06
Vnt 0.063 0.009 0.048 0.007 0.110 0.012
Vnpdh 0.33 0.01 0.32 0.01 0.34 0.01
Vout 0.62 0.02 0.67 0.03 0.53 0.04
Vpc 0.040 0.002 0.037 0.003 0.041 0.003
Vdil 0.18 0.02 0.14 0.03 0.31 0.09
Calculated fluxes
V
g
TCA 0.21 0.02 0.22 0.03 0.17 0.02
Vin 0.20 0.04 0.24 0.05 0.08 0.05
Vsyn 0.10 0.01 0.08 0.01 0.15 0.01
CMRglc(ox) 0.29 0.02 0.29 0.03 0.28 0.02
Note. The SD was determined by Monte Carlo analysis over 500
simulations.
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factor of 5 in the bonded cumomer model compared with
the positional model. Removing total enrichment in the
individual multiplet model resulted in an approximately
twofold increase of the FWHM of most ﬂuxes probability
distributions, as compared with the complete bonded
cumomer model.
The eﬀect of the applied modeling approach on the
correlation between metabolic ﬂuxes (Figure 5) was an
overall decrease of correlations between most metabolic
ﬂuxes when applying bonded cumomer modeling. Vout
and Vdil showed remarkably strong correlations in every
approach, more than 80%, independently of the addition
of the 13C multiplets turnover curves. However, introdu-
cing information about time courses of 13C multiplets of
Glu and Gln had signiﬁcant impact on reducing correl-
ation between Vnt and Vdil in the bonded cumomer model
and individual multiplet model, reduced from 80% to
45% and 30%, respectively.
On the other hand, removing information about total
13C enrichment of Glu and Gln in the individual multiplet
model increased slightly the correlation between several
ﬂuxes. For example, the correlation of Vdil with Vg
increased from 13% in bonded cumomer model to 57%
in individual multiplet model.
In addition, to visualize the improvements obtained
with the bonded cumomer model and better understand
the particular eﬀect of it on the correlation of Vnt and
Vdil, sensitivity analysis was undertaken for Vnt and Vdil.
In this analysis, the remaining metabolic ﬂuxes were
adapted through the nonlinear regression process to get
the best ﬁt of the total 13C enrichment curves with con-
strained Vnt or Vdil. Generally, the time courses of GluC4
and GlnC4 isotopomers showed the highest sensitivity to
Vnt and Vdil, which is illustrated in Figure 6. Total
13C
enrichment time courses of GlnC4 and GluC4 showed
low sensitivity to the constrained value of Vnt either in
the positional or bonded cumomer model. In the pos-
itional model, a combination of the remaining ﬂuxes
could compensate largely for the ﬁxed Vnt constraint,
except for the steady-state level of GlnC4 total enrich-
ment. On the contrary, the underlying 13C multiplet
time courses simulated for the positional modeling
approach showed a higher sensitivity to changes in Vnt
in particular for GlnC4 doublet and singlet curves. This
observation remained valid when including the 13C multi-
plet curves in the ﬁtting process (bonded cumomer
model), which shows that no combination of the remain-
ing adjusted parameters enabled to compensate for the
ﬁxed Vnt constraint.
13C-labeling curves for doublet
and singlet of GlnC4 changed in opposite direction for
increasing values of Vnt. As a consequence, the total
13C enrichment curve of GlnC4 was not signiﬁcantly
altered. Sensitivity analysis in both models showed
that 13C time courses of GluC4 isotopomers are not
as sensitive as GlnC4 to the value of Vdil. From this ana-
lysis, it also appeared that the sensitivity of total GlnC4
13C enrichment to the value of Vdil was a reﬂection of
GlnC4 singlet sensitivity, while its doublet remained
unchanged.
Discussion
This study demonstrates that using state of the art
dynamic 13C MRS data under 13C-glucose infusion, the
recently introduced concept of bonded cumomer meta-
bolic modeling approach provides an extension to the
estimation of neuroglial brain metabolic rates, reducing
in particular the correlations between most estimated
metabolic ﬂuxes in the brain. This kind of approach
was applied here for the ﬁrst time to an extended range
of isotopomers and total 13C enrichment curves of Glu
and Gln (total of 17 uptake curves), quantiﬁed from
group-averaged in vivo 13C spectra in rats. The advan-
tages of the bonded cumomer modeling approach and
its consistency with previously applied metabolic model-
ing approaches were evaluated on experimental data.
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Figure 5. Correlation matrix between metabolic fluxes estimated from the mathematical regression of the turnover curves of Glu and
Gln multiplets at position 4, 3, and 2 using (a) positional model, (b) bonded cumomer model, and (c) individual multiplet model.
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Preprocessing Approach for Reliable and Accurate
Quantification of Multiplets
Previous simulation studies suggested that the inclusion
of the time courses of individual 13C multiplets from
in vivo 13C MRS of the brain in the metabolic modeling
analysis can result in a signiﬁcant improvement in the
derivation of metabolic ﬂuxes, determined with better
precision (Shestov et al., 2012). Direct 13C NMR spec-
troscopy detection at 14.1T used here beneﬁts from
higher SNR and bigger chemical shift dispersion in the
NMR signal, potentially allowing higher temporal
resolution relative to lower ﬁelds (Duarte et al., 2011).
The increased chemical shift dispersion of 13C resonances
allowed to better separate the GluC3 and GlnC3 reson-
ances (Figure 2), which was not possible at lower ﬁeld
such as 9.4T (Henry et al., 2003b).
However, the detection and quantiﬁcation of ﬁne
structures of 13C multiplets by in vivo NMR spectroscopy
are hampered by inherent eﬀects of homonuclear spin–
spin J coupling, which is independent of the applied B0
magnetic ﬁeld strength. Therefore, although sensitivity
and chemical shift dispersion increase linearly with
the applied magnetic ﬁeld, the spectral separation of the
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Figure 6. Sensitivity analysis for the fluxes Vnt and Vdil plotted for the
13C labeling curves of GluC4 and GlnC4 for three different values of
Vnt (0.07, 0.1, and 0.20 mmol g
1 min1) and three different values of Vdil (0.20, 0.30, and 0.60 mmol g
1 min1) using positional model in the
top and bonded cumomer model in the bottom.
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13C multiplets (in ppm) decreases. However, with the
higher sensitivity allowed by surface coils, 1H decoupling
and eﬃcient B0 shimming using FAST(EST)MAP
(Gruetter and Tka´c, 2000) method at 14.1T provided
enough homogeneity (less than 10Hz linewidth) to clearly
distinguish the 13C multiplets in the spectral ﬁtting.
The total 13C enrichment of Glc, Glu, Gln, and Asp
were well determined with CRLB lower than 15% at
steady state when using a temporal resolution of
5.3min and SNR of 9 (spectra not shown). However, to
overcome the low signal amplitudes of some of the 13C
multiplets, temporal averaging was increased to 10.6min
and spectra were combined from four animals before
spectral quantiﬁcation, which altogether resulted in a
threefold elevation of SNR and better deﬁned 13C spec-
tral baseline. This allowed a more robust ﬁtting using
LCModel, which in turn resulted in more accurate and
reliable quantiﬁcation of 13C multiplets with CRLB less
than 15% at steady state (Figure 3).
Signiﬁcant overlap of the singlet with the center line of
the triplet in GluC3 and GlnC3 resulted in high problem
of cross correlation and quantiﬁcation are same for Glu
and Gln. Therefore, only the sum of singlet and triplet
multiplets was considered for the quantiﬁcation. The pre-
cision on the ﬁt of the sum of singlet and triplet in GluC3
and GlnC3 was systematically better than the precision of
the ﬁt when using singlet and triplet components
separately.
Overall, the increased resolution and sensitivity at
14.1T provided 13C enrichment turnover curves for
GluC4 total, GluC4 S, GluC4 D43, GluC3 total, GluC3
SþT, GluC3 D, GluC2 total, GluC2 S, GluC2 D23,
GlnC4 total, GlnC4 S, GlnC4 D43, GlnC3 total, GlnC3
SþT, GlnC3 D, GlnC2 total, GlnC2 S in brain in vivo,
all of which were with a precision of better than 15%
(CRLB) at steady state.
Positional Model
Nonlinear regression of the positional model to the total
measured 13C enrichment curves for Glu and Gln at pos-
ition C4, C3 and C2 resulted in seven independently
determined brain metabolic ﬂuxes, without a priori con-
straints (Table 1). The estimated ﬂuxes and calculated
CMRglc(ox) (0.28 0.02mmol/g/min) were overall com-
parable with previous 13C NMR studies done under
a-chloralose anesthesia (for CMRglc(ox): Hyder et al.,
1996; 0.18 0.3 mmol/g/min to 0.25 0.03mmol/g/min;
Sibson et al., 1998; 0.26 0.04mmol/g/min; Duarte
et al., 2011; 0.41 0.02 mmol/g/min; Jeﬀrey et al., 2013;
0.350.11mmol/g/min to 0.38 0.12mmol/g/min; Lanz
et al., 2014; 0.41 0.05mmol/g/min). When quantifying
the 13C spectra acquired from brain of four animals
using the traditional preprocessing approach as in
Duarte et al., 2011; namely spectral quantiﬁcation for
individual animals with time resolution of 5.3min and
averaging over the individually quantiﬁed data from
four animals, the obtained brain metabolic ﬂuxes using
time courses of total 13C enrichment of Glu and Gln for
carbon positions C2, C3, and C4 showed a signiﬁcantly
diﬀerent Vnt (p< .05, corrected for multiple comparison)
as the one estimated in this study (data not shown). The
SNR of 13C spectra acquired from every individual
animal brain with time resolution of 5.3min (SNR of 9
at steady state) was approximately three times lower than
the one obtained by combining the 13C spectra from four
animals with temporal average of 10.6min (SNR of 24 at
steady state). Not surprisingly, the lower SNR resulted in
13C multiplets determined with less precision, which likely
reduced the precision of the averaged time courses of 13C
multiplets. These results illustrate the importance of the
spectral preprocessing approach and spectral quality on
the estimation of brain metabolic ﬂuxes.
In this study, the exchange rate between cytosolic
amino acids and mitochondrial TCA cycle intermediates,
Vx, was estimated more precisely (with a relative error
lower than 5%) than in previous studies (Choi et al.,
2002; Henry et al., 2002). The estimated Vx was slightly
higher than the pyruvate dehydrogenase rate, Vnpdh and is
consistent with malate–aspartate shuttle being the major
mechanism for maintaining the cytosolic redox state
under normoxic conditions, as reported before
(Gruetter et al., 2001; de Graf et al,. 2004; Yang et al.,
2009; Lanz et al., 2014).
In the present work, Vnt was well determined with a
relative SD below 10% using positional modeling under
[1,6-13C2] glucose infusion (Table 1). The relative error of
all ﬂuxes except Vdil was lower than 10%, ascribed to the
high quality and SNR of the acquired 13C spectra at
14.1 T and the reﬁned preprocessing approach used for
spectral quantiﬁcation. Glial labeling dilution of the
acetyl-CoA pool, Vdil, had a slightly higher coeﬃcient
of variation (19%) and presented strong positive correl-
ation to the apparent rate of neurotransmission, Vnt. This
correlation was attributed to the observed diﬀerence in
13C labeling between Glu C4 and Gln C4. Vdil creates a
diﬀerence between the FEs of Glu and Gln while Vnt is
responsible for its dissipation by mixing the two pools.
Bonded Cumomer Model
The addition of dynamic time courses of 13C multiplets of
Glu and Gln to the input data for metabolic modeling
yielded smaller SDs for most ﬁtted metabolic rates com-
pared with positional modeling (Table 1). Probability
density functions for brain metabolic ﬂuxes estimated
by Monte Carlo simulations (Figure 4) indicated nar-
rower distributions compared with the positional
model, consistent with a higher precision of the deter-
mined ﬂuxes. One of the largest diﬀerences was found
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in dilution of 13C label at the level of glial acetyl-CoA,
Vdil, which was more precisely determined in the case of
the bonded cumomer model approach.
Using the bonded cumomer model, that is, the inclusion
of the dynamic 13C labeling of Glu and Gln multiplets in
metabolic modeling reduced the mathematical covariance
between most ﬁtted ﬂuxes compared with the positional
model (Figure 5). The assessment of Vdil using the pos-
itional model resulted in a large covariance between Vdil
and the apparent glutamatergic neurotransmission rate,
Vnt. The signiﬁcantly reduced covariance between Vdil
and Vnt in the bonded cumomer model is expected to
reduce the inﬂuence of Vdil on Vnt and should allow a
more precise and independent measurement of Vdil and
Vnt. Therefore, the distributions of Vdil and Vnt determined
with the bonded cumomer model are signiﬁcantly diﬀerent
from ones of the positional model (p¼ .0001 and .01,
respectively). Vout and Vdil showed remarkably strong cor-
relations in every approach, independently of the addition
of the 13C multiplet turnover curves of Glu and Gln, which
is probably due of the fact that both ﬂuxes contribute to
dilute the 13C enrichment at the level of acetyl-CoA.
Among the potential reasons for the higher precision
and independency of brain metabolic ﬂuxes is the simple
increased number of 13C time courses and experimental
information, arising from dynamic 13C enrichment of the
individual multiplets of Glu and Gln, as input in the
metabolic model, including partially redundant informa-
tion. However, a more important part is the sensitivity of
given 13C isotopomers labeling to particular ﬂuxes, which
are then averaged out when summing all the isotopomers
of the considered carbon position, which is evident in
Figure 6 for GlnC4 sensitivity analysis to Vnt and Vdil.
Sensitivity Analysis of GluC4 and GlnC4 Multiplets
to the Value of Vnt and Vdil
It is noteworthy that the 13C enrichment time courses of
total GlnC4 and total GluC4 13C enrichments were less
sensitive to Vnt than the individual
13C multiplets of
GluC4 and GlnC4; when increasing Vnt, the
13C enrich-
ment of the singlet of GluC4 decreased and the 13C enrich-
ment of the doublet of GluC4 increased, while the total
13C enrichment time course of GluC4 did not change
(Figure 6). The remaining metabolic ﬂuxes adapt to the
constraints ﬁxed on Vnt to provide a similar ﬁt quality for
total GluC4 in the positional model. This is a manifest-
ation of the higher correlation between Vnt and most of the
remaining ﬂuxes found with the positional modeling
approach (Figure 5). For GlnC4, on the other hand, the
total 13C enrichment curve is sensitive to Vnt resulting in
diﬀerences in the 13C turnover curve for diﬀerent con-
straints on Vnt. Nonetheless, the GlnC4 multiplet curves
exhibited also a stronger sensitivity to Vnt, in particular for
GlnC4 S, this already at early time points. As a
consequence, including the 13C multiplet curves in the
cost function of the regression led to a better-deﬁned
value of Vnt in the bonded cumomer model compared
with the positional model as well as a lower correlation
between Vnt and most other ﬂuxes in the bonded cumomer
model as summarized in Figure 5. Lower correlation of Vnt
with other ﬂuxes in the bonded cumomer model is
expected to result in a more independent estimation of
Vnt with less impact from other estimated ﬂuxes.
The above argument was based on the ﬂux Vnt, which
shows the strongest changes in terms of correlations with
other ﬂuxes between the positional model and the cumo-
mer model. However, note that a general reduction of the
correlation coeﬃcients between ﬂuxes is observed with
the cumomer model (Figure 5), leading to more precise
ﬂux measurements.
Shestov et al. (2007) also showed lower sensitivity of
simulated GlnC4 total 13C enrichment turnover curve to
the value of Vnt in the positional model. They concluded
that this eﬀect was a consequence of the fast 13C labeling
of the smaller glial Gln pool compared with its indirect
precursor, the large neuronal Glu pool. Glial Gln 13C
labeling therefore is largely inﬂuenced by the neuronal
Glu pool. However, our results show that changing Vnt
has an eﬀect on the 13C turnover curves of GlnC4 multi-
plets in the bonded cumomer model even though the total
13C enrichment of GlnC4 does not change signiﬁcantly.
This can be interpreted in terms of the diﬀerent precursors
of the essentially astrocytic Gln pool: The Gln pool reﬂects
the 13C enrichment of the small astrocytic Glu pool, which
can be labeled either from the glial TCA cycle or from the
neuronal TCA cycle via the neuronal Glu pool. However,
the 13C labeling patterns in the carbon positions 4 and 3 of
Glu generated by the astrocytic or the neuronal TCA cycle
are diﬀerent due to the dilution of the 13C labeling position
C3 in the glial TCA cycle through pyruvate carboxylase.
This can be seen by a lower total 13C enrichment in the C3
of Gln as compared with Glu (see Figure 3). The position
C4 is also diluted through metabolism of alternative sub-
strates in the astrocytic TCA cycle. Therefore, the prob-
ability of generating a doubly labeled C4–C3 Glu molecule
from the astrocytic TCA cycle is lower. Increasing the
relative value of Vnt will generate more Gln molecules
with carbon backbones originating from the neuronal
TCA cycle, with higher double C4–C3 labeling, increasing
the doublet component of GlnC4.
For the same reason, the 13C labeling time courses of
multiplets for Glu and Gln in both models showed that
the doublet of GlnC4 is not as sensitive as the singlet of
GlnC4 to changes in astrocytic Vdil, representing the glial
oxidative metabolism of alternative, unlabeled substrates.
Therefore, changes in the total GlnC4 enrichment reﬂect
the sensitivity of GlnC4 S to the value of Vdil while the
13C enrichment curve of GlnC4 D43 does not change
signiﬁcantly.
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Limitation of Modeling Based on 13C Labeling
Time Courses of Individual Multiplets
Removing total 13C enrichment curves from the bonded
cumomer model and considering just the 13C labeling of
individual multiplets had eﬀect on the estimated brain
metabolic ﬂuxes in terms of value, precision, and covari-
ance (Figures 4 and 5). The values found for the brain
metabolic rates listed in Table 1 were in the range
between those found with the positional model and the
full-bonded cumomer model. One drawback of excluding
the total 13C enrichment curves of Glu and Gln in the
bonded cumomer model is the reduction of the number of
13C time courses as input to the metabolic model.
Simulation and experimental studies veriﬁed that a
higher number of experimental 13C time courses of Glu
and Gln carbon positions increased the precision of esti-
mated brain metabolic ﬂuxes (Jeﬀrey et al., 1999; Shestov
et al., 2007). In addition, the spectral quantiﬁcation of the
13C multiplet time courses for Glu and Gln has a lower
precision due to their lower concentrations when com-
pared with the total 13C enrichment.
Using [1,6-13C2] glucose as a substrate and acquiring
13C spectra at a high ﬁeld of 14.1T in the present study
led to high peak intensities in the 13C multiplet reson-
ances of Glu and Gln at position C2, C3, and C4,
which made it easier to quantify 13C multiplet signals
with suﬃcient sensitivity. However, the 13C multiplets
are expected to be much more diﬃcult to detect and
quantify at lower magnetic ﬁelds, in particular when
infusing [1-13C] glucose and limiting the infusion experi-
ment to 60 to 90min, as typically undertaken in
human studies for cost and practical reasons (Rothman
et al., 2011). Therefore, the use of [1-13C] glucose
remains a limitation for a reliable and accurate quantiﬁ-
cation of time courses for individual 13C multiplets
of metabolites.
Early studies on brain extracts (Taylor et al., 1996)
proved that coinfusion of [1-13C] glucose and [1,2-13C2]
acetate resulted in diﬀerent 13C isotopomer patterns that
reﬂect predominantly neuronal and glial metabolism,
respectively. The feasibility of measuring dynamic 13C
multiplet data in brain arising from simultaneous infu-
sion of [1,6-13C2] glucose and [1,2-
13C2] acetate in vivo has
been reported previously (Deelchand et al., 2009).
Simultaneous infusion of labeled glucose and acetate is
therefore of more interest in terms of amount of infor-
mation arising from isotopomer 13C labeling for brain
metabolic modeling. Shestov et al. (2012) showed with
simulated data that the best precision in estimating
brain metabolic ﬂuxes was obtained in the case of
double infusion of [1,6-13C2] glucose and [1,2-
13C2] acet-
ate. Therefore, future in vivo studies with simultaneous
infusion of labeled glucose and acetate could take better
advantage of dynamic multiplet analysis.
Conclusion
We conclude that incorporating the 13C labeling time
courses of multiplets of Glu and Gln measured by 13C
MRS at high magnetic ﬁeld (14.1 T) in the neuronal–glial
metabolic model brings improvement in the reliability
and independency of estimated brain metabolic ﬂuxes.
An extended analysis of 13C multiplet time courses of
metabolites in vivo requires infusion of doubly-labeled
Glc as substrate and strong B0 magnetic ﬁeld in order
to get both enough 13C enrichment and acceptable SNR
in 13C multiplets spectra. Therefore, this reﬁned modeling
approach may be only applicable for preclinical studies
on small animals.
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Appendix
For each multiplet, the index C shows the carbon posi-
tion in the molecule and the next letter, separated by
space, gives the multiplet ﬁne structure (S is for singlet,
D for doublet, and T for triplet).
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In following equations, the indexes b and p specify
metabolic pools in brain and plasma, respectively.
Metabolic pools in the neuronal compartment are indi-
cated with the index n and in the glial compartment with
the index g.
The TCA cycle rate in the neuronal compartment, ﬂux
through pyruvate dehydrogenase: Vnpdh
The TCA cycle rate in the glial compartment:
VgTCA ¼ Vg þ Vpc
Flux through neuronal glutaminase: Vnt
The anaplerotic ﬂux through pyruvate carboxylase: Vpc
Glutamate-alpha–ketoglutarate and oxaloacetate–
aspartate exchange rate: Vx
Outﬂow and inﬂow of labeling at the level of Lactate:
Vout and Vin
The dilution ﬂux at the level of acetyl-CoA: Vdil
A-1. Glucose Transport Across the Blood–Brain
Barrier
Brain glucose concentration using a reversible Michaelis–
Menten kinetics for glucose transport across the blood–
brain barrier change according to following expression:
d
dt
Glc tð Þb  ¼ Tmax Glc tð Þp½   Glc tð Þb
 
=Vd
Kt þ Glc tð Þ
b½ 
Vd
þ Glc tð Þp½ 
 CMRGlc:
Tmax: The apparent maximal transport rate
Kt: The apparent Michaelis constant for glucose
transport
Vd: The physical volume of distribution for glucose in
the brain, 0.77ml/g
A-2. Mass Balance Equations of Particular Interest
With steady-state assumption for the Glu and Gln label-
ing pools in the case of [1,6-13C2] Glc infusion, the total
concentration of the labeling pools as well as the meta-
bolic ﬂuxes between the pools be assumed to remain same
over the duration of the measurement. Thus, maintaining
the mass balance equations results in following expres-
sions (Henry et al., 2006; Lanz et al., 2013)
d
dt
½Lacb ¼ Vin  Vout þ 2CMRglc  Vnpdh  Vg  2Vpc ¼ 0:
d
dt
½OAAg ¼ Vx þ Vpc  Vx  Vsyn þ Vnt ¼ 0:
d
dt
½Glug ¼ Vpc  Vsyn þ Vnt ¼ 0
d
dt
½Glng ¼ Vsyn  Vefflux  Vnt ¼ 0:
The Gln synthesis rate in glial: Vsyn ¼ Vnt þ Vpc:
The net Gln eﬄux: Vefflux ¼ Vpc:
The fraction of Glucose metabolized at steady-state in
the TCA cycle: CMRglcðoxÞ ¼ V
n
pdh
þVg
TCA
þVpc
2 :
The cerebral metabolic rate of Glucose consumption:
CMRglc ¼ CMRglcðoxÞ þ VoutVin2 :
A-3. Metabolic Equations for Isotopomers Labeling
in Bonded Cumomer Model
{i}, { j}, and {k} indicate the positions of labeled carbon
in metabolite. M if g refers to the sum of isotopomers frac-
tions labeled at least at position {i} and interpreted as the
probability of labeling metabolite at position i. M i, jf g is
the probability of metabolite being labeled at adjacent
positions i and j. M i, j, kf g indicates the probability meta-
bolite being labeled at three adjacent position i, j, and k
(Shestov et al,, 2012).
Transport of 13C-enriched carbons of glucose.
Glc tð Þb  d
dt
bGlc if g
 
¼ Tmax
Glc tð Þp½  pGlc if g
 
 Glc tð Þb =Vd bGlc if g 
Kt þ Glc tð Þ
b½ 
Vd
þ Glc tð Þp½ 
 CMRGlc bGlc if g
 
:
Glc tð Þb  d
dt
b
Glc i, jf g
 
¼ Tmax
Glc tð Þp½  p
Glc i, jf g
 
 Glc tð Þb =Vd bGlc i, jf g
 
Kt þ Glc tð Þ
b½ 
Vd
þ Glc tð Þp½ 
 CMRGlc bGlc i, jf g
 
:
Glc tð Þb  d
dt
b
Glc i, j, kf g
 
¼ Tmax
Glc tð Þp½  p
Glc i, j, kf g
 
 Glc tð Þb =Vd bGlc i, j, kf g
 
Kt þ Glc tð Þ
b½ 
Vd
þ Glc tð Þp½ 
 CMRGlc bGlc i, j, kf g
 
:
Enrichment of neuronal amino acids.
Glun½ : d
dt
nGlu if g
  ¼ Vx nOG if g þ Vnt nGln if g 
 ðVx þ VntÞ nGlu if g
 
:
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Glun½ : d
dt
n
Glu i, jf g
 
¼ Vx nOG i, jf g
 
þ Vnt nGln i, jf g
 
 ðVx þ VntÞ nGlu i, jf g
 
:
Glun½ : d
dt
n
Glu i, j, kf g
 
¼ Vx nOG i, j, kf g
 
þ Vnt nGln i, j, kf g
 
 ðVx þ VntÞ nGlu i, j, kf g
 
:
Glnn½ : d
dt
nGln if g
 
¼ Vnt gGln if g
 
 Vnt nGln if g
 
:
Glnn½ : d
dt
n
Gln i, jf g
 
¼ Vnt gGln i, jf g
 
 Vnt nGln i, jf g
 
:
Glnn½ : d
dt
n
Gln i, j, kf g
 
¼ Vnt gGln i, j, kf g
 
 Vnt nGln i, j, kf g
 
:
Aspn½ : d
dt
nAsp if g
 
¼ Vx nOAA if g
 
 Vx nAsp if g
 
:
Aspn½ : d
dt
n
Asp i, jf g
 
¼ Vx nOAA i, jf g
 
 Vx nAsp i, jf g
 
:
Aspn½ : d
dt
n
Asp i, j, kf g
 
¼ Vx nOAA i, j, kf g
 
 Vx nAsp i, j, kf g
 
:
Enrichment of glial amino acids.
Glug½ : d
dt
gGlu if g
 
¼ Vx þ Vpc
 
gOG if g
 
þ Vnt nGlu if g
 
 Vx þ Vnt þ Vpc
 
gGlu if g
 
:
Glug½ : d
dt
g
Glu i, jf g
 
¼ ðVx þ VpcÞ gOG i, jf g
 
þ Vnt nGlu i, jf g
 
 ðVx þ Vnt þ VpcÞ gGlu i, jf g
 
:
Glug½ : d
dt
g
Glu i, j, kf g
 
¼ Vx þ Vpc
 
g
OG i, j, kf g
 
þ Vnt nGlu i, j, kf g
 
 ðVx þ Vnt þ VpcÞ gGlu i, j, kf g
 
:
Glng½ : d
dt
gGln if g
 
¼ ðVnt þ VpcÞ gGlu if g
 
 Vnt þ Vpc
 
gGln if g
 
:
Glng½ : d
dt
g
Gln i, jf g
 
¼ Vnt þ Vpc
 
g
Glu i, jf g
 
 Vnt þ Vpc
 
g
Gln i, jf g
 
:
Glng½ : d
dt
g
Gln i, j, kf g
 
¼ Vnt þ Vpc
 
g
Glu i, j, kf g
 
 Vnt þ Vpc
 
g
Gln i, j, kf g
 
:
Aspg½ : d
dt
gAsp if g
 
¼ Vx gOAA if g
 
 Vx gAsp if g
 
:
Aspg½ : d
dt
g
Asp i, jf g
 
¼ Vx gOAA i, jf g
 
 Vx gAsp i, jf g
 
:
Aspg½ : d
dt
g
Asp i, j, kf g
 
¼ Vx gOAA i, j, kf g
 
 Vx gAsp i, j, kf g
 
:
Enrichment of single brain pyruvate pool by considering its fast
equilibrium with lactate.
Pyr½ : d
dt
pyr 1f g
pyr 2f g
pyr 3f g
0
BB@
1
CCA ¼ CMRGlc
bGlc 3f g þ bGlc 4f g
bGlc 2f g þ bGlc 5f g
bGlc 1f g þ bGlc 6f g
0
BBB@
1
CCCA
 Vout þ 2Vpc þ Vg þ Vnpdh
 

pyr 1f g
pyr 2f g
pyr 3f g
0
BB@
1
CCA
þ 2Vpc þ Vg þ Vnpdh þ Vout  2CMRGlc
 

pLac 1f g
pLac 2f g
pLac 3f g
0
BB@
1
CCA:
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Pyr½  d
dt
pyr 1, 2f g
pyr 2, 3f g
 	
¼ CMRGlc
bGlc 2, 3f g þ bGlc 4, 5f g
bGlc 1, 2f g þ bGlc 5, 6f g
 !
 Vout þ 2Vpc þ Vg þ Vnpdh
  pyr 1, 2f g
pyr 2, 3f g
 	
þ 2Vpc þ Vg þ Vnpdh þ Vout  2CMRGlc
  pLac 1, 2f g
pLac 2, 3f g
 !
:
Pyr½  d
dt
pyr 1, 2, 3f g
 
¼ CMRGlc bGlc 1, 2, 3f g þ bGlc 4, 5, 6f g
 
 Vout þ 2Vpc þ Vg þ Vnpdh
 
pyr 1, 2, 3f g
 
þ 2Vpc þ Vg þ Vnpdh þ Vout  2CMRGlc
 
pLac 1, 2, 3f g
 
:
Enrichment of acetyl-CoA.
AcCoAg½  d
dt
gAcCoA 1f g
gAcCoA 2f g
 !
¼ Vdil
gAce 1f g
gAce 2f g
 !
þ Vg þ Vpc
  gpyr 2f g
gpyr 3f g
 !
 ðVdil þ Vg þ VpcÞ
gAcCoA 1f g
gAcCoA 2f g
 !
:
AcCoAg½  d
dt
gAcCoA 1, 2f g
 
¼ Vdil gAce 1, 2f g
 þ Vg þ Vpc  gpyr 2, 3f g 
 Vdil þ Vg þ Vpc
 
gAcCoA 1, 2f g
 
:
Enrichment of neuronal TCA cycle intermediates.
OGn½  d
dt
nOG 1f g
nOG 2f g
nOG 3f g
nOG 4f g
nOG 5f g
0
BBBBBB@
1
CCCCCCA
¼ Vnpdh
nOAA 4f g
nOAA 3f g
nOAA 2f g
npyr 3f g
npyr 2f g
0
BBBBBB@
1
CCCCCCA
þ Vx
nGlu 1f g
nGlu 2f g
nGlu 3f g
nGlu 4f g
nGlu 5f g
0
BBBBBB@
1
CCCCCCA
 ðVnpdh þ VxÞ
nOG 1f g
nOG 2f g
nOG 3f g
nOG 4f g
nOG 5f g
0
BBBBBB@
1
CCCCCCA
:
OGn½  d
dt
nOG 1, 2f g
nOG 2, 3f g
nOG 3, 4f g
nOG 4, 5f g
0
BBB@
1
CCCA
¼ Vnpdh
nOAA 3, 4f g
nOAA 2, 3f g
nOAA 2f g
n
pyr 3f g
npyr 2, 3f g
0
BBB@
1
CCCA
þ Vx
nGlu 1, 2f g
nGlu 2, 3f g
nGlu 3, 4f g
nGlu 4, 5f g
0
BBB@
1
CCCA Vnpdh þ Vx
  
n
OG 1, 2f g
nOG 2, 3f g
nOG 3, 4f g
nOG 4, 5f g
0
BBB@
1
CCCA:
OGn½  d
dt
nOG 1, 2, 3f g
nOG 2, 3, 4f g
nOG 3, 4, 5f g
0
B@
1
CA ¼ Vnpdh
nOAA 2, 3, 4f g
npyr 3f g
n
OAA 2, 3f g
nOAA 2f g
n
pyr 2, 3f g
0
B@
1
CA
þ Vx
nGlu 1, 2, 3f g
nGlu 2, 3, 4f g
nGlu 3, 4, 5f g
0
B@
1
CA ðVnpdh þ VxÞ
nOG 1, 2, 3f g
nOG 2, 3, 4f g
nOG 3, 4, 5f g
0
B@
1
CA:
OAAn½  d
dt
nOAA 1f g
nOAA 2f g
nOAA 3f g
nOAA 4f g
0
BBB@
1
CCCA ¼ V
n
pdh
2
nOG 2f g þ nOG 5f g
nOG 3f g þ nOG 4f g
nOG 3f g þ nOG 4f g
nOG 2f g þ nOG 5f g
0
BBB@
1
CCCA
þ Vx
nAsp 1f g
nAsp 2f g
nAsp 3f g
nAsp 4f g
0
BBB@
1
CCCA Vnpdh þ Vx
  
n
OAA 1f g
nOAA 2f g
nOAA 3f g
nOAA 4f g
0
BBB@
1
CCCA:
OAAn½  d
dt
nOAA 1, 2f g
nOAA 2, 3f g
nOAA 3, 4f g
0
B@
1
CA ¼ Vnpdh
2
nOG 2, 3f g þ nOG 4, 5f g
2nOG 3, 4f g
nOG 2, 3f g þ nOG 4, 5f g
0
B@
1
CA
þ Vx
nAsp 1, 2f g
nAsp 2, 3f g
nAsp 3, 4f g
0
B@
1
CA Vnpdh þ Vx 
nOAA 1,2f g
nOAA 2, 3f g
nOAA 3, 4f g
0
B@
1
CA:
OAAn½  d
dt
nOAA 1, 2, 3f g
nOAA 2, 3, 4f g
 !
¼ V
n
pdh
2
nOG 2, 3, 4f g þ nOG 3, 4, 5f g
nOG 2, 3, 4f g þ nOG 3, 4, 5f g
 !
þ Vx
nAsp 1, 2, 3f g
nAsp 2, 3, 4f g
 !
 Vnpdh þ Vx
  nOAA 1, 2, 3f g
nOAA 2, 3, 4f g
 !
:
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OGg½  d
dt
gOG 1f g
gOG 2f g
gOG 3f g
gOG 4f g
gOG 5f g
0
BBBBBBB@
1
CCCCCCCA
¼ Vg þ Vpc
 
gOAA 4f g
gOAA 3f g
gOAA 2f g
gAcCoA 2f g
gAcCoA 1f g
0
BBBBBBB@
1
CCCCCCCA
þ Vx
gGlu 1f g
gGlu 2f g
gGlu 3f g
gGlu 4f g
gGlu 5f g
0
BBBBBBB@
1
CCCCCCCA
 Vg þ Vx þ Vpc
 
gOG 1f g
gOG 2f g
gOG 3f g
gOG 4f g
gOG 5f g
0
BBBBBBB@
1
CCCCCCCA
:
OGg½  d
dt
gOG 1, 2f g
gOG 2, 3f g
gOG 3, 4f g
gOG 4,5f g
0
BBBB@
1
CCCCA ¼ Vg þ Vpc
 
gOAA 3, 4f g
gOAA 2, 3f g
gOAA 2f g
g
AcCoA 2f g
gAcCoA 1, 2f g
0
BBBB@
1
CCCCA
þ Vx
gGlu 1, 2f g
gGlu 2, 3f g
gGlu 3, 4f g
gGlu 4, 5f g
0
BBBB@
1
CCCCA Vg þ Vx þ Vpc
 
gOG 1, 2f g
gOG 2, 3f g
gOG 3, 4f g
gOG 4, 5f g
0
BBBB@
1
CCCCA:
OGg½  d
dt
gOG 1, 2, 3f g
gOG 2, 3, 4f g
gOG 3, 4, 5f g
0
B@
1
CA ¼ Vg þ Vpc 
gOAA 2, 3, 4f g
gOAA 2, 3f g
g
AcCoA 2f g
gOAA 2f g
g
AcCoA 1, 2f g
0
B@
1
CA
þ Vx
gGlu 1, 2, 3f g
gGlu 2, 3, 4f g
gGlu 3, 4, 5f g
0
B@
1
CA Vg þ Vx þ Vpc 
gOG 1, 2, 3f g
gOG 2, 3, 4f g
gOG 3, 4, 5f g
0
B@
1
CA:
OAAg½  d
dt
gOAA 1f g
gOAA 2f g
gOAA 3f g
gOAA 4f g
0
BBBB@
1
CCCCA ¼
Vg
2
gOG 2f g þ gOG 5f g
gOG 3f g þ gOG 4f g
gOG 3f g þ gOG 4f g
gOG 2f g þ gOG 5f g
0
BBBB@
1
CCCCA
þ Vx
gAsp 1f g
gAsp 2f g
gAsp 3f g
gAsp 4f g
0
BBBB@
1
CCCCA Vg þ Vx þ Vpc
 
gOAA 1f g
gOAA 2f g
gOAA 3f g
gOAA 4f g
0
BBBB@
1
CCCCA
þ Vpc
gpyr 1f g
gpyr 2f g
gpyr 3f g
CO2
0
BBB@
1
CCCA:
OAAg½  d
dt
gOAA 1, 2f g
gOAA 2, 3f g
gOAA 3, 4f g
0
B@
1
CA
¼ Vg
2
gOG 2, 3f g þ gOG 4, 5f g
2gOG 3, 4f g
gOG 2, 3f g þ gOG 4, 5f g
0
B@
1
CAþ Vx
gAsp 1, 2f g
gAsp 2, 3f g
gAsp 3, 4f g
0
B@
1
CA
 Vg þ Vx þ Vpc
  gOAA 1, 2f g
gOAA 2, 3f g
gOAA 3, 4f g
0
B@
1
CAþ Vpc
gpyr 1, 2f g
gpyr 2, 3f g
CO2
g
pyr 3f g
0
B@
1
CA:
OAAg½  d
dt
gOAA 1, 2, 3f g
gOAA 2, 3, 4f g
 !
¼ Vg
2
gOG 2, 3, 4f g þ gOG 3, 4, 5f g
gOG 2, 3, 4f g þ gOG 3, 4, 5f g
 !
þ Vx
gAsp 1, 2, 3f g
gAsp 2, 3, 4f g
 !
 Vg þ Vx þ Vpc
  gOAA 1, 2, 3f g
gOAA 2, 3, 4f g
 !
þ Vpc
gpyr 1, 2, 3f g
gpyr 2, 3f gCO2
 !
:
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